1. Home
  2. AXTI vs SNTI Comparison

AXTI vs SNTI Comparison

Compare AXTI & SNTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AXTI
  • SNTI
  • Stock Information
  • Founded
  • AXTI 1986
  • SNTI 2016
  • Country
  • AXTI United States
  • SNTI United States
  • Employees
  • AXTI N/A
  • SNTI N/A
  • Industry
  • AXTI Semiconductors
  • SNTI Biotechnology: Pharmaceutical Preparations
  • Sector
  • AXTI Technology
  • SNTI Health Care
  • Exchange
  • AXTI Nasdaq
  • SNTI Nasdaq
  • Market Cap
  • AXTI 84.8M
  • SNTI 85.3M
  • IPO Year
  • AXTI 1998
  • SNTI N/A
  • Fundamental
  • Price
  • AXTI $2.56
  • SNTI $2.40
  • Analyst Decision
  • AXTI Strong Buy
  • SNTI Strong Buy
  • Analyst Count
  • AXTI 4
  • SNTI 2
  • Target Price
  • AXTI $4.69
  • SNTI $8.50
  • AVG Volume (30 Days)
  • AXTI 728.8K
  • SNTI 378.2K
  • Earning Date
  • AXTI 07-31-2025
  • SNTI 08-12-2025
  • Dividend Yield
  • AXTI N/A
  • SNTI N/A
  • EPS Growth
  • AXTI N/A
  • SNTI N/A
  • EPS
  • AXTI N/A
  • SNTI N/A
  • Revenue
  • AXTI $96,029,000.00
  • SNTI N/A
  • Revenue This Year
  • AXTI N/A
  • SNTI N/A
  • Revenue Next Year
  • AXTI $27.18
  • SNTI $150.00
  • P/E Ratio
  • AXTI N/A
  • SNTI N/A
  • Revenue Growth
  • AXTI 21.44
  • SNTI N/A
  • 52 Week Low
  • AXTI $1.13
  • SNTI $1.52
  • 52 Week High
  • AXTI $4.03
  • SNTI $16.94
  • Technical
  • Relative Strength Index (RSI)
  • AXTI 69.02
  • SNTI 40.19
  • Support Level
  • AXTI $1.97
  • SNTI $2.10
  • Resistance Level
  • AXTI $2.49
  • SNTI $2.35
  • Average True Range (ATR)
  • AXTI 0.15
  • SNTI 0.22
  • MACD
  • AXTI 0.02
  • SNTI 0.03
  • Stochastic Oscillator
  • AXTI 89.13
  • SNTI 30.97

About AXTI AXT Inc

AXT Inc is a developer and producer of compound and single element semiconductor substrates, also known as wafers. The dominant substrates used in producing semiconductor chips and other electronic circuits are made from silicon. It is engaged in the design, development, manufacture, and distribution of high-performance compound semiconductor substrates and the sale of materials. The company provides alternative or specialty materials in the form of substrates or wafers, including compound and single-element substrates. Its compound substrates combine indium with phosphorous or gallium with arsenic. Geographically firm has its business presence across the region of Europe, Japan, Taiwan, China, North America, and the Asia Pacific from which China derives its maximum revenue to the company.

About SNTI Senti Biosciences Inc.

Senti Biosciences Inc is a clinical-stage biotechnology company developing next-generation cell and gene therapies engineered with its gene circuit platform technologies for patients living with incurable diseases. The product candidates utilize allogeneic chimeric antigen receptor natural killer (CAR-NK) cells outfitted with its gene circuit technologies in various oncology indications. The company product candidates include SENTI-202, a Logic Gated off-the-shelf CAR-NK cell therapy designed to target and eliminate cancer cells while sparing the healthy bone marrow; and SENTI-301A for the treatment of hepatocellular carcinoma.

Share on Social Networks: